Comparison of escherichia coli strains as agents for bacterial interference

Infection Control and Hospital Epidemiology

Volumn 31, Issue 6, 2010, Pages 659-661

  Darouiche, Rabih O ^a,c   Riosa, Sarah ^a,c   Hull, Richard A ^b,c  

^a Center for Prostheses Infection   (United States)

^b Department of Molecular Virology and Microbiology ^*  (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CATHETER INFECTION; COMPARATIVE STUDY; ESCHERICHIA COLI; HUMAN; NONHUMAN; PHENOTYPE; STRAIN DIFFERENCE; URINARY CATHETER; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANTIBIOSIS; ESCHERICHIA COLI; HUMANS; URINARY TRACT INFECTIONS;

EID: 77952223627     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/653070     Document Type: Article

References (10)

1. Darouiche RO. Infections in patients with spinal cord injury. In: Mandeli GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Elsevier Churchill Livingstone, 2010:3851-3856.
2. Darouiche RO, Donovan WH, Del Terzo M, Thornby JI, Rudy DC, Hull RA. Pilot trial of bacterial interference for preventing urinary tract infection. Urology 2001;58:339-344. (Pubitemid 32816345)
3. Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005;41:1531-1534. (Pubitemid 41580001)
4. Trautner BW, Hull RA, Darouiche RO. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 2003; 61:1059-1062.
5. Klemm PV, Roos V, Ulett GC, Svanborg C, Schembri MA. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 2006;74:781-785. (Pubitemid 43023139)
6. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991;4:80-128.
7. HullRA,RudyDC,DonovanWH,WieserIE,StewartC,DarouicheRO. VirulencepropertiesofEscherichiacoli83972, aprototypestrainassociatedwithasymptomaticbacteriuria.InfectImmun1999;67: 429-432.(Pubitemid29021682)
8. Hull RA, Donovan WH, Del Terzo M, Stewart C, Rogers M, Darouiche RO. Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Inject Immun 2002;70:6481-6484. (Pubitemid 35192746)
9. Trautner BW, Hull RA, Thornby JI, Darouiche RO. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Inject Control Hosp Epidemiol 2007;28:92-94.
10. Trautner BW, Cevallos ME, Li H, et al. Increased expression of type 1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis 2008;198:899-906.